A total of 137 patients suffering from bronchial asthma (BA) and concomitant allergic rhinitis (AR) were available for the examination.
OPEN FILEThese findings suggest that the mechanism of LLLT treatment of asthma is by adjustment of Th1/Th2 imbalance. Thus, LLLT could take over some of the effects of budesonide for the treatment of asthma, thereby reducing some of the side effects of budesonide.
OPEN FILEThus, photobiomodulation may be considered a promising tool for the treatment of chronic pulmonary allergic inflammation observed in asthma.
OPEN FILEFrom the website of Dr. Andy Hall: https://ipflaserstudy.com/
OPEN FILEThere is evidence that LLLT is able to modulate the immune system at the skin and joint, and it has been shown to be efficacious in humans by affecting bacterial colonization as it may pertain to chronic rhinosinusitis.
OPEN FILE...the review clearly demonstrates that various methods of laser illumination make it possible to influence almost all the known pathogenesis of the disease, and low-level laser therapy is a truly effective method of treatment.
OPEN FILELow-level laser therapy (LLLT) controls bronchial hyperresponsiveness (BHR) associated with increased RhoA expression as well as pro-inflammatory mediators associated with NF-kB in acute lung inflammation.
OPEN FILE